マーケットレポート詳細
生殖補助医療(ART)の世界市場：2031年予測
Assisted Reproductive Technology Market (Technology: In Vitro Fertilization, Artificial Insemination, Surrogacy, and Others; and Procedure: Frozen Donor, Frozen Non-donor, Fresh Donor, Fresh Non-donor, and Embryo Banking) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
- 出版元：Transparency Market Research
出版元について - 発行年：2023年12月
- 定価 ：Single User License(1名様ライセンス)US$5,795(米国ドル)/Multi User License(5名様)$8,795 /Enterprise License $11,705
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文189ページになります。
- 商品コード：TMR161
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
生殖補助医療（ART）の世界市場規模は2022年で259億ドル、2031年に586億ドル、市場の平均年成長率は9.4%に増で推移する見通しです。
当レポートでは、生殖補助医療（ART）の市場予測-2031年、各種セグメント別市場分析(技術別、エンドユーザー別、国地域別、等)、COVID-19の影響、競合状況、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
■生殖補助医療（ART）の世界市場予測2017-2031年
・市場規模(US$)
■技術別、市場-2031年
体外受精
・顕微授精(ICSI)
・着床前遺伝子検査（PGD）
人工授精
・子宮腔内精子注入法（IUI）
・子宮頸管内人工授精（ICI）
・その他
代理出産
その他
※(市場規模US$)
■手続き別、市場-2031年
凍結ドナー
凍結非ドナー
新鮮ドナー
新鮮非ドナー
胚バンク
※(市場規模US$)
■エンドユーザー別、市場-2031年
不妊治療クリニック
病院
その他
※(市場規模US$)
■主要国地域別市場-2031年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
■市場分析
市場ダイナミクス（促進要因、障壁、機会）
パイプライン分析
COVID-19の影響
競合状況
市場シェア分析
SWOT分析
■生殖補助医療（ART）の主要企業プロフィール動向
Merck KGaA
CooperSurgical, Inc.
FUJIFILM Irvine Scientific.
Vitrolife AB
Hamilton Thorne, Inc.
株式会社ニコン
Nidacon International AB
Laboratoire CCD
Esco Micro Pte. Ltd.
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Assisted Reproductive Technology Market
4. Market Overview
4.1. Introduction
4.1.1. Technology Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Assisted Reproductive Technology Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Technology/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Assisted Reproductive Technology Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technology, 2017–2031
6.3.1. In Vitro Fertilization
6.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
6.3.1.2. Preimplantation Genetic Diagnosis (PGD)
6.3.2. Artificial Insemination
6.3.2.1. Intrauterine Insemination (IUI)
6.3.2.2. Intracervical Insemination (ICI)
6.3.2.3. Others
6.3.3. Surrogacy
6.3.4. Others
6.4. Market Attractiveness Analysis, by Technology
7. Global Assisted Reproductive Technology Market Analysis and Forecast, by Procedure
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Procedure, 2017–2031
7.3.1. Frozen Donor
7.3.2. Frozen Non-donor
7.3.3. Fresh Donor
7.3.4. Fresh Non-donor
7.3.5. Embryo Banking
7.4. Market Attractiveness Analysis, by Procedure
8. Global Assisted Reproductive Technology Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Fertility Clinics
8.3.2. Hospitals
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Assisted Reproductive Technology Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Assisted Reproductive Technology Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Technology, 2017–2031
10.3.1. In Vitro Fertilization
10.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
10.3.1.2. Preimplantation Genetic Diagnosis (PGD)
10.3.2. Artificial Insemination
10.3.2.1. Intrauterine Insemination (IUI)
10.3.2.2. Intracervical Insemination (ICI)
10.3.2.3. Others
10.3.3. Surrogacy
10.3.4. Others
10.4. Market Value Forecast, by Procedure, 2017–2031
10.4.1. Frozen Donor
10.4.2. Frozen Non-donor
10.4.3. Fresh Donor
10.4.4. Fresh Non-donor
10.4.5. Embryo Banking
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Fertility Clinics
10.5.2. Hospitals
10.5.3. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Technology
10.7.2. By Procedure
10.7.3. By End-user
10.7.4. By Country
11. Europe Assisted Reproductive Technology Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Technology, 2017–2031
11.3.1. In Vitro Fertilization
11.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
11.3.1.2. Preimplantation Genetic Diagnosis (PGD)
11.3.2. Artificial Insemination
11.3.2.1. Intrauterine Insemination (IUI)
11.3.2.2. Intracervical Insemination (ICI)
11.3.2.3. Others
11.3.3. Surrogacy
11.3.4. Others
11.4. Market Value Forecast, by Procedure, 2017–2031
11.4.1. Frozen Donor
11.4.2. Frozen Non-donor
11.4.3. Fresh Donor
11.4.4. Fresh Non-donor
11.4.5. Embryo Banking
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Fertility Clinics
11.5.2. Hospitals
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Technology
11.7.2. By Procedure
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Assisted Reproductive Technology Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Technology, 2017–2031
12.3.1. In Vitro Fertilization
12.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
12.3.1.2. Preimplantation Genetic Diagnosis (PGD)
12.3.2. Artificial Insemination
12.3.2.1. Intrauterine Insemination (IUI)
12.3.2.2. Intracervical Insemination (ICI)
12.3.2.3. Others
12.3.3. Surrogacy
12.3.4. Others
12.4. Market Value Forecast, by Procedure, 2017–2031
12.4.1. Frozen Donor
12.4.2. Frozen Non-donor
12.4.3. Fresh Donor
12.4.4. Fresh Non-donor
12.4.5. Embryo Banking
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Fertility Clinics
12.5.2. Hospitals
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Technology
12.7.2. By Procedure
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Assisted Reproductive Technology Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Technology, 2017–2031
13.3.1. In Vitro Fertilization
13.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
13.3.1.2. Preimplantation Genetic Diagnosis (PGD)
13.3.2. Artificial Insemination
13.3.2.1. Intrauterine Insemination (IUI)
13.3.2.2. Intracervical Insemination (ICI)
13.3.2.3. Others
13.3.3. Surrogacy
13.3.4. Others
13.4. Market Value Forecast, by Procedure, 2017–2031
13.4.1. Frozen Donor
13.4.2. Frozen Non-donor
13.4.3. Fresh Donor
13.4.4. Fresh Non-donor
13.4.5. Embryo Banking
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Fertility Clinics
13.5.2. Hospitals
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Technology
13.7.2. By Procedure
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Assisted Reproductive Technology Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Technology, 2017–2031
14.3.1. In Vitro Fertilization
14.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
14.3.1.2. Preimplantation Genetic Diagnosis (PGD)
14.3.2. Artificial Insemination
14.3.2.1. Intrauterine Insemination (IUI)
14.3.2.2. Intracervical Insemination (ICI)
14.3.2.3. Others
14.3.3. Surrogacy
14.3.4. Others
14.4. Market Value Forecast, by Procedure, 2017–2031
14.4.1. Frozen Donor
14.4.2. Frozen Non-donor
14.4.3. Fresh Donor
14.4.4. Fresh Non-donor
14.4.5. Embryo Banking
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Fertility Clinics
14.5.2. Hospitals
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Technology
14.7.2. By Procedure
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Merck KGaA
15.3.1.1. Company Overview
15.3.1.2. Technology Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. CooperSurgical, Inc.
15.3.2.1. Company Overview
15.3.2.2. Technology Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. FUJIFILM Irvine Scientific
15.3.3.1. Company Overview
15.3.3.2. Technology Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Vitrolife AB
15.3.4.1. Company Overview
15.3.4.2. Technology Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Hamilton Thorne, Inc.
15.3.5.1. Company Overview
15.3.5.2. Technology Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Nikon Corporation
15.3.6.1. Company Overview
15.3.6.2. Technology Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Nidacon International AB
15.3.7.1. Company Overview
15.3.7.2. Technology Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Laboratoire CCD
15.3.8.1. Company Overview
15.3.8.2. Technology Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Esco Micro Pte. Ltd.
15.3.9.1. Company Overview
15.3.9.2. Technology Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
List of Tables
Table 01: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 02: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 03: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 07: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 08: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 11: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 12: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 15: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 16: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 19: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 20: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 23: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 24: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Assisted Reproductive Technology Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031
Figure 02: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Technology, 2022
Figure 03: Global Assisted Reproductive Technology Market Value Share, by Technology, 2022
Figure 04: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Procedure, 2022
Figure 05: Global Assisted Reproductive Technology Market Value Share, by Procedure, 2022
Figure 06: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Assisted Reproductive Technology Market Value Share, by End-user, 2022
Figure 08: Global Assisted Reproductive Technology Market Value Share, by Region, 2022
Figure 09: Global Assisted Reproductive Technology Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 11: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
Figure 12: Global Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 13: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 14: Global Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 15: Global Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2022-2031
Figure 16: Global Assisted Reproductive Technology Market Value Share Analysis, by Region, 2022 and 2031
Figure 17: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Region, 2022-2031
Figure 18: North America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Assisted Reproductive Technology Market Value Share Analysis, by Country, 2022 and 2031
Figure 21: North America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 22: North America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 23: North America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 24: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031
Figure 25: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 26: North America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 30: Europe Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 31: Europe Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 32: Europe Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 33: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031
Figure 34: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 35: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 39: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 40: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 41: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 42: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031
Figure 43: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 44: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 48: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 49: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 50: Latin America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031
Figure 52: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 53: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 57: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 58: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 59: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031
Figure 61: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 62: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031